153 related articles for article (PubMed ID: 25964945)
1. Cost-effectiveness of the chronic disease self-management program: implications for community-based organizations.
Basu R; Ory MG; Towne SD; Smith ML; Hochhalter AK; Ahn S
Front Public Health; 2015; 3():27. PubMed ID: 25964945
[TBL] [Abstract][Full Text] [Related]
2. The impact of chronic disease self-management programs: healthcare savings through a community-based intervention.
Ahn S; Basu R; Smith ML; Jiang L; Lorig K; Whitelaw N; Ory MG
BMC Public Health; 2013 Dec; 13():1141. PubMed ID: 24314032
[TBL] [Abstract][Full Text] [Related]
3. Healthcare cost savings estimator tool for chronic disease self-management program: a new tool for program administrators and decision makers.
Ahn S; Smith ML; Altpeter M; Post L; Ory MG
Front Public Health; 2015; 3():42. PubMed ID: 25964946
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of a Community Exercise and Nutrition Program for Older Adults: Texercise Select.
Akanni OO; Smith ML; Ory MG
Int J Environ Res Public Health; 2017 May; 14(5):. PubMed ID: 28531094
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights.
Norrlid H; Dahm P; Tennvall GR
Scand J Pain; 2015 Jan; 6(1):24-30. PubMed ID: 29911578
[TBL] [Abstract][Full Text] [Related]
6. Successes of a national study of the Chronic Disease Self-Management Program: meeting the triple aim of health care reform.
Ory MG; Ahn S; Jiang L; Smith ML; Ritter PL; Whitelaw N; Lorig K
Med Care; 2013 Nov; 51(11):992-8. PubMed ID: 24113813
[TBL] [Abstract][Full Text] [Related]
7. Evaluation Design of EFFICHRONIC: The Chronic Disease Self-Management Programme (CDSMP) Intervention for Citizens with a Low Socioeconomic Position.
Tan SS; Pisano MM; Boone AL; Baker G; Pers YM; Pilotto A; Valsecchi V; Zora S; Zhang X; Fierloos I; Raat H
Int J Environ Res Public Health; 2019 May; 16(11):. PubMed ID: 31142017
[No Abstract] [Full Text] [Related]
8. Incremental cost-effectiveness of adult spinal deformity surgery: observed quality-adjusted life years with surgery compared with predicted quality-adjusted life years without surgery.
McCarthy I; O'Brien M; Ames C; Robinson C; Errico T; Polly DW; Hostin R;
Neurosurg Focus; 2014 May; 36(5):E3. PubMed ID: 24785485
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ventricular assist device programme in the UK.
Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
[TBL] [Abstract][Full Text] [Related]
10. Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.
Noyes K; Dick AW; Holloway RG;
Pharmacoeconomics; 2005; 23(12):1257-70. PubMed ID: 16336019
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of case management for optimized antithrombotic treatment in German general practices compared to usual care - results from the PICANT trial.
Ulrich LR; Petersen JJ; Mergenthal K; Berghold A; Pregartner G; Holle R; Siebenhofer A
Health Econ Rev; 2019 Feb; 9(1):4. PubMed ID: 30729350
[TBL] [Abstract][Full Text] [Related]
12. Modeled cost-effectiveness of transforaminal lumbar interbody fusion compared with posterolateral fusion for spondylolisthesis using N(2)QOD data.
Carreon LY; Glassman SD; Ghogawala Z; Mummaneni PV; McGirt MJ; Asher AL
J Neurosurg Spine; 2016 Jun; 24(6):916-21. PubMed ID: 26895529
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Effectiveness of a Self-Management Program on Patients Living with Chronic Diseases.
Bahari G; Kerari A
Risk Manag Healthc Policy; 2024; 17():487-496. PubMed ID: 38449511
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community.
Hebert PL; Sisk JE; Wang JJ; Tuzzio L; Casabianca JM; Chassin MR; Horowitz C; McLaughlin MA
Ann Intern Med; 2008 Oct; 149(8):540-8. PubMed ID: 18936502
[TBL] [Abstract][Full Text] [Related]
16. A secondary analysis of the moderating effects of depression and multimorbidity on the effectiveness of a chronic disease self-management programme.
Harrison M; Reeves D; Harkness E; Valderas J; Kennedy A; Rogers A; Hann M; Bower P
Patient Educ Couns; 2012 Apr; 87(1):67-73. PubMed ID: 21767927
[TBL] [Abstract][Full Text] [Related]
17. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
18. Chronic disease self-management program in the workplace: opportunities for health improvement.
Smith ML; Wilson MG; DeJoy DM; Padilla H; Zuercher H; Corso P; Vandenberg R; Lorig K; Ory MG
Front Public Health; 2014; 2():179. PubMed ID: 25964909
[TBL] [Abstract][Full Text] [Related]
19. A Cost-Effectiveness Analysis of a Randomized Control Trial of a Tailored, Multifactorial Program to Prevent Falls Among the Community-Dwelling Elderly.
Matchar DB; Eom K; Duncan PW; Lee M; Sim R; Sivapragasam NR; Lien CT; Ong MEH
Arch Phys Med Rehabil; 2019 Jan; 100(1):1-8. PubMed ID: 30165053
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
